NCT04620356

Brief Summary

Children vary in the age at which they achieve night-time dryness; in almost all cases children will stop bed-wetting without any need for treatment. Use of absorbent pants for the management of nocturnal enuresis is controversial regarding the impact on the speed at which children become dry throughout the night. The aim of this study is to determine the effect of using DryNites absorbent pants in children with monosymptomatic nocturnal enuresis on the speed they become dry throughout the night compared with removing absorbent pants.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
105

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 21, 2020

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

September 23, 2020

Completed
2 months until next milestone

First Posted

Study publicly available on registry

November 9, 2020

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 28, 2023

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 28, 2023

Completed
1.4 years until next milestone

Results Posted

Study results publicly available

December 6, 2024

Completed
Last Updated

December 6, 2024

Status Verified

October 1, 2024

Enrollment Period

2.9 years

First QC Date

September 23, 2020

Results QC Date

December 26, 2023

Last Update Submit

October 21, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Wet Nights

    Average number of wet nights

    Last week of the 4-week intervention period

Secondary Outcomes (4)

  • Impact of Urinary Incontinence on Emotional Wellbeing of Child as Assessed by Paediatric Incontinence Questionnaire (PinQ)

    Assessment will be done at each study clinic visit (Day 56 +/- 7)

  • Impact of Child Nighttime Enuresis on Parent/Carer Quality of Life as Assessed by the WHOQoL-BREF Questionnaire

    Assessment will be done at each study clinic visit (Day 56 +/- 7)

  • Child Daytime Sleepiness as Assessed by PDSS Questionnaire

    Assessment will be done at each study clinic visit (Day 56 +/- 7)

  • Parent/Carer Fatigue as Assessed by Checklist Individual Strength (CIS Questionnaire)

    Assessment will be done at each study clinic visit (Day 56 +/- 7 )

Study Arms (2)

DryNites arm

EXPERIMENTAL

Participants in this arm use DryNites every night for 4 weeks ("run-in" period), an additional 4 weeks (intervention "core trial" period), and an optional additional 4 weeks ("extension" period). All participants in this arm also receive absorbent bad mats to use every night.

Device: DryNites Pyjama Pants

No Pants arm

NO INTERVENTION

Participants in this arm use DryNites every night for 4 weeks only during the initial "run-in" period. Thereafter, participants in this arm do not use DryNites during the 4 week intervention "core trial" period or the optional additional 4 weeks "extension" period. All participants in this arm also receive absorbent bad mats to use every night.

Interventions

DryNites Pyjama Pants are disposable, absorbent youth pants designed to help children manage bed wetting by absorbing involuntary urine loss and protecting the child's garments and bedding. DryNites Pyjama Pants are underwear-like alternatives that can be discreetly worn beneath pyjamas or nightwear during the bedwetting phase.

DryNites arm

Eligibility Criteria

Age4 Years - 8 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Patient aged between 4-8 years at the time of enrollment
  • Have a clinical diagnosis of monosymptomatic primary NE
  • Have been dry in the day for \>/= 6 months prior to enrollment
  • Have on average no more than 1 dry night per month during the past 6 months at enrollment
  • Have an informed consent signed by the their parent(s)/carer(s)

You may not qualify if:

  • Children in foster/court care
  • Have implemented any previous intervention to address NE (use of prescribed alarm schedule, desmopressin, imipramine, anticholinergics) or withdrawal of pants/nappies for \> 7 days in the previous 6 months
  • Have secondary NE
  • Have wetting in the day
  • Have faecal soiling
  • Have known urinary tract disease
  • Have diabetes
  • Receive any regular intake of medication
  • Have a known developmental/neurological disorder
  • Have links to Kimberly-Clark of any kind (including family relations employed by Kimberly-Clark, holding stocks or share in Kimberly-Clark)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Mounts Bay Medical

Connor, Haley, TR27 5DT, United Kingdom

Location

Siddarth Marnekar

Hull, HU12 8JD, United Kingdom

Location

Related Publications (1)

  • Breinbjerg A, Kamperis K, Thorsteinsson K, Jorgensen CS, Dossche L, Rayner J, Zhang J, Rodrigues DG, Borch L, Hagstrom S, Tekgul S, Walle JV, Rittig S. Discontinuing absorbent pants in children with bedwetting: a randomized controlled trial. Eur J Pediatr. 2024 May;183(5):2443-2453. doi: 10.1007/s00431-024-05502-w. Epub 2024 Mar 12.

MeSH Terms

Conditions

Nocturnal Enuresis

Condition Hierarchy (Ancestors)

EnuresisUrination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesBehavioral SymptomsBehaviorElimination DisordersMental Disorders

Results Point of Contact

Title
Clinical Science Manager
Organization
kimberlyClark

Study Officials

  • Søren Riting

    Department of Pediatrics, Aarhus University Hospital, Aarhus, Denmark

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 23, 2020

First Posted

November 9, 2020

Study Start

February 21, 2020

Primary Completion

January 28, 2023

Study Completion

June 28, 2023

Last Updated

December 6, 2024

Results First Posted

December 6, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

Locations